Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies.

Pires da Silva I, Glitza IC, Haydu LE, Johnpulle R, Banks PD, Grass GD, Goldinger SMA, Smith JL, Everett AS, Koelblinger P, Roberts-Thomson R, Millward M, Atkinson VG, Guminski A, Kapoor R, Conry RM, Carlino MS, Wang W, Shackleton MJ, Eroglu Z, Lo S, Hong AM, Long GV, Johnson DB, Menzies AM.

Pigment Cell Melanoma Res. 2019 Jul;32(4):553-563. doi: 10.1111/pcmr.12775. Epub 2019 Mar 3.

PMID:
30767428
2.

Melanoma: do we need a hatchet or a scalpel?

Shackleton MJ, Quintana E, Fullen DR, Sabel MS, Johnson TM.

Arch Dermatol. 2009 Mar;145(3):307-8. doi: 10.1001/archdermatol.2009.3. No abstract available.

PMID:
19289763
3.

Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma.

Cebon J, J├Ąger E, Shackleton MJ, Gibbs P, Davis ID, Hopkins W, Gibbs S, Chen Q, Karbach J, Jackson H, MacGregor DP, Sturrock S, Vaughan H, Maraskovsky E, Neumann A, Hoffman E, Sherman ML, Knuth A.

Cancer Immun. 2003 Jul 16;3:7.

Supplemental Content

Loading ...
Support Center